Class I (most serious) Drug D-0772-2026 Ongoing

FDA Class I recall: an injectable out of specification for bacterial endotoxin — the pyrogen that survives killing the bacteria (Victory Medical Center Pharmacy)

Victory Medical Center Pharmacy Reported Aug 19, 2026

The U.S. Food and Drug Administration classified a glutathione injectable (200 mg/mL, 30 mL vial) prepared by Victory Medical Center Pharmacy as Class I — its most serious category. The reason is microbial contamination of a sterile product: out-of-specification results were obtained for bacterial endotoxin. The quantity is 91 units, distributed nationwide.

Recall overview (primary data)

  • ClassificationClass I (most serious)
  • Product typeDrug
  • Recalling firmVictory Medical Center Pharmacy
  • ReasonMicrobial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
  • DistributionUSA Nationwide
  • Recall initiated2026-07-01

Key points

  • Recall number D-0772-2026; FDA Class I, the most serious category; status Ongoing.
  • The product is a glutathione injectable (MDV), 200 mg/mL, 30 mL vial, recorded as containing ascorbic acid and benzyl alcohol 1.5% among other ingredients.
  • The reason is microbial contamination of a sterile product, with out-of-specification results for bacterial endotoxin.
  • Endotoxin is heat-stable and persists after the bacteria are killed, so it is measured separately from sterility.
  • Quantity 91 units, distributed nationwide. The recalling firm is a pharmacy in Texas. Initiated 2026-07-01; reported 2026-08-19.
  • Of the 1,408 FDA recall records this site holds as of 2026-09-01, 17 name endotoxin as the reason.

1Endotoxin survives killing the bacteria

Bacterial endotoxin is a component of the outer cell wall of Gram-negative bacteria, a lipopolysaccharide. Its defining property is that it persists after the organism itself is dead. Heat and sterilization can kill the bacteria, but endotoxin is heat-stable and can remain in the product.

For that reason, injectables are tested for endotoxin separately from any test of sterility. Endotoxin reaching the bloodstream provokes fever and an inflammatory response, and in sufficient quantity can lead to a severe systemic reaction. That this recall is stated as microbial contamination of a sterile product while the concrete failure is an out-of-specification endotoxin result reflects exactly that two-part control.

2The multi-dose vial format

The MDV in the product name stands for multi-dose vial — a vial designed for repeated withdrawals from a single container. The benzyl alcohol 1.5% in the recorded formulation is an ingredient commonly used as a preservative, so that organisms do not grow as the stopper is punctured again and again.

A preservative, however, is meant to suppress the growth of organisms introduced later; it does nothing about endotoxin already present at the time of manufacture. And the multi-dose format means a fault in one vial can extend across several administrations.

391 units, distributed nationwide

The quantity is 91 units, and the party conducting the recall is a pharmacy rather than a pharmaceutical manufacturer. The formulation on the record is a specific mixture of several ingredients, which is the form of an injectable prepared at a facility rather than a ready-made approved product. Small as the quantity is, distribution reached across the country.

4Seventeen records cite endotoxin

Of the 1,408 FDA recall records this site holds as of 2026-09-01, 17 name endotoxin in the reason for recall.

Records citing endotoxin17 / 1408

Against the many records that turn on sterility itself, few cite the quantity of a pyrogen. The absence of organisms and the absence of what organisms left behind are separate requirements, and the second is only visible once it is measured. The small count reflects a failure that cannot be seen without testing, not a rare problem.

Why it matters

The quality of an injectable rests on two independent requirements: sterility and the endotoxin limit. Because a sterilization step kills organisms without removing endotoxin, the practical control point is preventing growth in the first place — in raw materials, equipment, and water. For injectables prepared in small quantities at a facility, process records and testing frequency translate directly into outcomes. With a multi-dose vial, one faulty container reaches several administrations, so identifying what was affected has to extend into administration records.

FAQ

What is bacterial endotoxin?
A lipopolysaccharide component of the outer cell wall of Gram-negative bacteria. It is heat-stable and persists after the organism is killed, so its quantity is tested separately from sterility.
Why is endotoxin a problem if the product is sterile?
Because sterilization kills bacteria but leaves endotoxin behind. Reaching the bloodstream it provokes fever and an inflammatory response, and in sufficient quantity can lead to a severe systemic reaction.
What does MDV mean?
Multi-dose vial — a vial intended for repeated withdrawals from one container. The benzyl alcohol in the recorded formulation is an ingredient commonly used as a preservative for repeated use.

Sources (primary)

Source: openFDA (U.S. FDA, CC0 public domain). Data is provided as-is and must not be used for medical decisions. Verify the latest and exact details with the official FDA recall information. This site is not endorsed or certified by the U.S. FDA.

#FDA#Recall#Class I#Drug#Injectable#Endotoxin#Sterility
Disclaimer: This site independently summarizes and classifies information based on official data sources. Always verify the latest and accurate information with the official sources. Content on finance, health, legal, and security is information, not advice. This site is not an official website of the U.S. government.